NCT02740387View on ClinicalTrials.gov

Open Label Study of OTO-104 in Subjects With Meniere's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Meniere's Disease
Interventions
DRUG

OTO-104

Trial Locations (1)

Unknown

Call Otonomy call center for trial locations, London

Sponsors

Lead Sponsor

Otonomy, Inc.
All Listed Sponsors
lead

Otonomy, Inc.

INDUSTRY